Dew, I was disappointed in lack of response to this good question: Which one is a better platform for slow-release delivery to the back of the eye? I saw a poster on Yahoo QLTI board suggesting Atrigel was a tested and approved platform in the form of Eligard. Much would depend on the size and removability of the implanted device from the eye. It might take an insider familiar with each technology to have an opinion worth anything.
Market Data 
Markets 
AI
